PRESS RELEASE published on 04/28/2023 at 18:35, 1 year 5 months ago Dufry upgraded by Moody’s to Ba3 with Positive Outlook
PRESS RELEASE published on 04/26/2023 at 07:00, 1 year 5 months ago Invitation to Dufry’s First Quarter 2023 Trading Update
PRESS RELEASE published on 04/03/2023 at 17:50, 1 year 5 months ago Dufry Publishes Invitation to its Ordinary General Meeting on May 08, 2023
PRESS RELEASE published on 03/30/2023 at 07:00, 1 year 5 months ago Dufry with S&P Rating Upgrade to BB- and CreditWatch Positive
PRESS RELEASE published on 03/07/2023 at 06:31, 1 year 6 months ago Dufry delivers 2022 targets on a rising tide of global travel with Turnover of CHF 6,878.4 million, CORE EBITDA margin of 8.8% and EFCF of CHF 305.2 million
PRESS RELEASE published on 02/21/2023 at 17:45, 1 year 7 months ago Invitation to Dufry’s Full Year Results 2022 Presentation on March 7th, 2023
PRESS RELEASE published on 02/07/2023 at 07:00, 1 year 7 months ago Dufry announces new Global Executive Committee
PRESS RELEASE published on 02/03/2023 at 20:00, 1 year 7 months ago Combination between Dufry and Autogrill successfully closed
PRESS RELEASE published on 01/06/2023 at 19:15, 1 year 8 months ago Business Combination between Dufry and Autogrill
Published on 09/28/2024 at 02:06, 21 hours 19 minutes ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 21 hours 25 minutes ago Quantum Biopharma Provides Corporate Update
Published on 09/28/2024 at 02:00, 21 hours 25 minutes ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 23 hours 15 minutes ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 9 hours 23 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 1 hour ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 4 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 4 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 5 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 5 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 5 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 5 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024